CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 2, 2006--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Bank of America 2006 Specialty Pharmaceuticals Conference on Thursday, August 10, 2006 at 11:15 a.m. ET at the Southampton Inn, Southampton, New York.
